ML

May Liu

Vp, Corporate Controller at Astellas Gene Therapies

May Liu has a strong background in finance and administration, with experience in various leadership roles. May has worked as the VP, Corporate Controller at Audentes Therapeutics since September 2018. Prior to that, they served as the Senior VP, Finance & Administration, Principal Financial Officer at Anthera Pharmaceuticals from April 2007 to August 2018. Before that, May worked as the SEC Reporting Manager at Renovis, Inc. from September 2005 to March 2007. May began their career as an Audit Manager at Ernst & Young, where they worked from September 2000 to August 2005.

May Liu attended San Francisco State University, but no information is provided about the start or end year, degree obtained, or field of study.

Links

Previous companies

EY logo

Timeline

  • Vp, Corporate Controller

    September, 2018 - present

View in org chart